Trials / Sponsors / Multiple Myeloma Research Consortium
Multiple Myeloma Research Consortium
Network · 4 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Horizon Two Adaptive Platform Study in High Risk Newly Diagnosed Multiple Myeloma High Risk Newly Diagnosed Multiple Myeloma | Phase 2 | 2025-10-01 |
| Recruiting | MMRC Horizon One Adaptive Platform Trial Evaluating Therapies in RRMM Relapse Multiple Myeloma, Refractory Multiple Myeloma | Phase 2 | 2024-11-17 |
| Terminated | Immuno-Oncology Drugs Elotuzumab, Anti-LAG-3 and Anti-TIGIT Multiple Myeloma, Relapsed Refractory Multiple Myeloma | Phase 1 / Phase 2 | 2020-07-10 |
| Completed | Myeloma-Developing Regimens Using Genomics (MyDRUG) Relapsed Refractory Multiple Myeloma | Phase 1 / Phase 2 | 2019-04-01 |